Teleflex Incorporated which can be found using ticker (TFX) now have 13 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between 330 and 241 calculating the average target price we see $274.54. Now with the previous closing price of $245.34 this is indicating there is a potential upside of 11.9%. Also worth taking note is the 50 day moving average now sits at $253.77 while the 200 day moving average is $236.19. The market capitalization for the company is 11.14B. The stock price is currently at: 237.27 USD
The potential market cap would be $12,471,433,665 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 30.98, revenue per share of 60.97 and a 4.97% return on assets.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers. It markets and sells its products worldwide through a combination of its direct sales force and distributors. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its segment includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, which provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, specialized sutures and performance fibers, bioabsorbable sutures, yarns and resins.
